PMID- 40971494
OWN - NLM
STAT- Publisher
LR  - 20250919
IS  - 1528-0020 (Electronic)
IS  - 0006-4971 (Linking)
DP  - 2025 Sep 19
TI  - Reprogramming glutamine metabolism enhances BCMA-CART cell fitness and 
      therapeutic efficacy in multiple myeloma.
LID - blood.2024027496 [pii]
LID - 10.1182/blood.2024027496 [doi]
AB  - Glutamine-dependence of cancer cells reduces local glutamine availability, which 
      hinders anti-tumor T-cell functionality and facilitates immune evasion. We thus 
      speculated that glutamine deprivation might be limiting efficacy of CAR T-cell 
      therapies in cancer patients. We have seen that antigen-specific T cells are 
      unable to proliferate or produce IFN-γ in response to antigen stimulation when 
      glutamine concentration is limited. Using multiple myeloma (MM) as a 
      glutamine-dependent disease model, we found that murine CAR-T cells selectively 
      targeting BCMA in MM cells were sensitive to glutamine deprivation. However, 
      CAR-T cells engineered to increase glutamine uptake by expression of the 
      glutamine transporter Asct2 exhibited enhanced proliferation and responsiveness 
      to antigen stimulation, increased production of IFN-γ, and heightened cytotoxic 
      activity, even under conditions of low glutamine concentration. Mechanistically, 
      Asct2 overexpression reprogrammed CART cell metabolic fitness of CART cells by 
      upregulating the mTORC1 gene signature, modifying the Solute Carrier transporter 
      (SLC) repertoire, and improving both basal oxygen consumption rate and glycolytic 
      function thereby enhancing CART cell persistence in vivo. Accordingly, expression 
      of Asct2 increased the efficacy of BCMA-CART cells in syngeneic and 
      genetically-engineered mouse models of MM, which prolonged mouse survival. In 
      patients, reduced expression of Asct2 by MM cells predicted poor outcome to 
      combined immunotherapy and BCMA-CAR T-cell therapy. Our results indicate that 
      reprogramming glutamine metabolism may enhance anti-tumor CAR T-cell 
      functionality in MM. This approach may also be effective for other cancers that 
      depend on glutamine as a key energy source and metabolic hallmark.
CI  - Copyright © 2025 American Society of Hematology.
FAU - Navarro, Flor
AU  - Navarro F
AD  - Centro de Investigación Médica Aplicada, CIMA, Pamplona, Spain.
FAU - Lozano, Teresa
AU  - Lozano T
AUID- ORCID: 0000-0001-7122-5475
AD  - Centro de Investigación Médica Aplicada, CIMA, Pamplona, Spain.
FAU - Fuentes-García, Andrea
AU  - Fuentes-García A
AD  - Centro de Investigación Médica Aplicada, CIMA, Barcelona, Spain.
FAU - Sánchez-Moreno, Inés
AU  - Sánchez-Moreno I
AD  - Centro de Investigación Médica Aplicada, CIMA, Pamplona, Spain.
FAU - Larrayoz, Marta
AU  - Larrayoz M
AD  - CIMA, Pamplona, Spain.
FAU - Justicia, Pedro
AU  - Justicia P
AUID- ORCID: 0000-0002-6823-7747
AD  - Centro de Investigación Médica Aplicada, CIMA, Pamplona, Spain.
FAU - Perucha, Beatriz
AU  - Perucha B
AD  - Centro de Investigación Médica Aplicada, CIMA, Pamplona, Spain.
FAU - Martinez-Tabar, Maialen
AU  - Martinez-Tabar M
AUID- ORCID: 0009-0001-3209-633X
AD  - Centro de Investigación Médica Aplicada, CIMA, Pamplona, Spain.
FAU - Martinez-Turrillas, Rebeca
AU  - Martinez-Turrillas R
AUID- ORCID: 0000-0003-1013-7898
AD  - Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain.
FAU - Casares, Noelia
AU  - Casares N
AUID- ORCID: 0000-0003-3817-6434
AD  - Center for Applied Medical Research, CIMA, Pamplona, Spain.
FAU - Martín-Otal, Celia
AU  - Martín-Otal C
AD  - Centro de Investigación Médica Aplicada, CIMA, Pamplona, Spain.
FAU - Gorraiz, Marta
AU  - Gorraiz M
AD  - Centro de Investigación Médica Aplicada, CIMA, Pamplona, Spain.
FAU - Meermeier, Erin W
AU  - Meermeier EW
AUID- ORCID: 0000-0002-9709-7624
AD  - Mayo Clinic, Scottsdale, Arizona, United States.
FAU - Chesi, Marta
AU  - Chesi M
AUID- ORCID: 0000-0002-4024-8225
AD  - Mayo Clinic, Scottsdale, Arizona, United States.
FAU - Lake, Douglas
AU  - Lake D
AD  - Arizona State University, Phoenix, Arizona, United States.
FAU - Bergsagel, Paul Leif
AU  - Bergsagel PL
AUID- ORCID: 0000-0003-1523-7388
AD  - Mayo Clinic, Scottsdale, Arizona, United States.
FAU - Santamaría, Eva
AU  - Santamaría E
AUID- ORCID: 0000-0003-0629-6175
AD  - Centro de Investigación Médica Aplicada, CIMA, Pamplona, Spain.
FAU - Calleja-Cervantes, Maria Erendira
AU  - Calleja-Cervantes ME
AUID- ORCID: 0000-0003-0688-0793
AD  - Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain.
FAU - San Martín-Úriz, Patxi
AU  - San Martín-Úriz P
AUID- ORCID: 0000-0003-1483-4279
AD  - Foundation for Applied Medical Research, University of Navarra, Pamplona, Spain.
FAU - Jordana-Urriza, Lorea
AU  - Jordana-Urriza L
AD  - Foundation for Applied Medical Research, University of Navarra, Pamplona, Spain.
FAU - Agirre, Xabier
AU  - Agirre X
AUID- ORCID: 0000-0002-6558-9560
AD  - Foundation for Applied Medical Research, University of Navarra, Pamplona, Spain.
FAU - Hervas-Stubbs, Sandra
AU  - Hervas-Stubbs S
AUID- ORCID: 0000-0003-3391-1516
AD  - Centre for Applied Medical Research, Pamplona, Spain.
FAU - Rodriguez-Madoz, Juan Roberto
AU  - Rodriguez-Madoz JR
AUID- ORCID: 0000-0003-4327-1866
AD  - Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain.
FAU - Martínez-Climent, Jose A
AU  - Martínez-Climent JA
AD  - Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, 
      Spain.
FAU - Prosper, Felipe
AU  - Prosper F
AUID- ORCID: 0000-0001-6115-8790
AD  - Clinica Universidad de Navarra, Pamplona, Spain.
FAU - Lasarte, Juan J
AU  - Lasarte JJ
AUID- ORCID: 0000-0003-1641-3881
AD  - Centro de Investigación Médica Aplicada, CIMA, Pamplona, Spain.
LA  - eng
PT  - Journal Article
DEP - 20250919
PL  - United States
TA  - Blood
JT  - Blood
JID - 7603509
SB  - IM
EDAT- 2025/09/19 18:31
MHDA- 2025/09/19 18:31
CRDT- 2025/09/19 14:19
PHST- 2025/08/01 00:00 [accepted]
PHST- 2024/10/30 00:00 [received]
PHST- 2025/08/01 00:00 [revised]
PHST- 2025/09/19 18:31 [medline]
PHST- 2025/09/19 18:31 [pubmed]
PHST- 2025/09/19 14:19 [entrez]
AID - 547364 [pii]
AID - 10.1182/blood.2024027496 [doi]
PST - aheadofprint
SO  - Blood. 2025 Sep 19:blood.2024027496. doi: 10.1182/blood.2024027496.
